We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Mounjaro is being made available via GPs for patients with a BMI of 40 or higher, PLUS four of the following weight-related health conditions: type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease. Giffords will be offering this service once funding is in place. We will contact all patients who are eligible in the coming few weeks.
Published: Jun 24, 2025